PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.00%
Negative net income growth while ECL.AX stands at 0.00%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.25%
Share change of 0.25% while ECL.AX is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
OCF growth of 0.00% while ECL.AX is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
0.00%
FCF growth of 0.00% while ECL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-29.23%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
220.47%
5Y revenue/share CAGR above 1.5x ECL.AX's 69.39%. David Dodd would look for consistent product or market expansions fueling outperformance.
106.00%
3Y revenue/share CAGR above 1.5x ECL.AX's 67.55%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
-243.98%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-423.72%
Negative 5Y OCF/share CAGR while ECL.AX is at 123.80%. Joel Greenblatt would question the firm’s operational model or cost structure.
-668.95%
Negative 3Y OCF/share CAGR while ECL.AX stands at 703.65%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
206.95%
Below 50% of ECL.AX's 1107.00%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
499.00%
5Y net income/share CAGR above 1.5x ECL.AX's 19.60%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
60.24%
3Y net income/share CAGR 1.25-1.5x ECL.AX's 51.59%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
No Data
No Data available this quarter, please select a different quarter.
1826.40%
5Y equity/share CAGR above 1.5x ECL.AX's 1.09%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
116.90%
3Y equity/share CAGR above 1.5x ECL.AX's 15.72%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
7.95%
AR growth of 7.95% while ECL.AX is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.25%
We have a declining book value while ECL.AX shows 0.00%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.